Yvonne Arvidsson Selected Research

N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)

1/2017	NAMPT Inhibitor GMX1778 Enhances the Efficacy of 177Lu-DOTATATE Treatment of Neuroendocrine Tumors.
1/2005	Antitumoural effects of the pyridyl cyanoguanidine CHS 828 on three different types of neuroendocrine tumours xenografted to nude mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yvonne Arvidsson Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 09/2003
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2010
3	Carcinoid Tumor (Carcinoid) 06/2010 - 01/2005
1	Hyperplasia 01/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2013
1	Hypoxia (Hypoxemia) 06/2010
1	Leukemia 07/2008
1	Sarcoma (Soft Tissue Sarcoma) 07/2008
1	Thyroid Neoplasms (Thyroid Cancer) 01/2005
1	Neuroblastoma 01/2005
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2003

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2003
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2017
2	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2017 - 05/2013
2	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 01/2017 - 01/2005
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2017 - 05/2013
2	Peptide Receptors (Peptide Receptor)IBA 01/2017 - 05/2013
2	Tyrosine Kinase InhibitorsIBA 01/2016 - 05/2013
1	Smad4 ProteinIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2018
1	CateninsIBA 01/2018
1	177Lu-octreotateIBA 12/2017
1	lutetium Lu 177 dotatateIBA 01/2017
1	Radioisotopes (Radionuclides)IBA 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	EP2 Subtype Prostaglandin E ReceptorsIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Histones (Histone)IBA 01/2016
1	somatostatin receptor type 1IBA 05/2013
1	indium-111-octreotideIBA 05/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2010
1	CXC ChemokinesIBA 06/2010
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 06/2010
1	SynaptophysinIBA 06/2008
1	Amyloid (Amyloid Fibrils)IBA 06/2008
1	ProdrugsIBA 01/2005
1	EnzymesIBA 01/2005
1	Transcription Factors (Transcription Factor)IBA 01/2005
1	Adenomatous Polyposis Coli ProteinIBA 09/2003

Therapy/Procedure

3	Therapeutics 12/2017 - 01/2005
2	Radiotherapy 05/2013 - 06/2010
1	Aftercare (After-Treatment) 01/2016
1	Drug Therapy (Chemotherapy) 06/2010